VolitionRx Limited (VNRX)
NYSEAMERICAN: VNRX · IEX Real-Time Price · USD
0.760
+0.017 (2.29%)
Mar 28, 2024, 2:50 PM EDT - Market open
VolitionRx Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for VolitionRx stock have an average target of 3.75, with a low estimate of 2.00 and a high estimate of 6.00. The average target predicts an increase of 393.42% from the current stock price of 0.76.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for VolitionRx stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Oct '23 | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 | 2 |
Buy | 1 | 2 | 2 | 2 | 2 | 2 |
Hold | 1 | 1 | 1 | 1 | 1 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 5 | 6 | 6 | 6 | 6 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $2.5 | Buy | Reiterates | $2.5 | +228.95% | Mar 27, 2024 |
EF Hutton | EF Hutton | Strong Buy Maintains $4.5 | Strong Buy | Maintains | $4.5 | +492.11% | Mar 27, 2024 |
EF Hutton | EF Hutton | Strong Buy Reiterates $4.5 | Strong Buy | Reiterates | $4.5 | +492.11% | Jan 2, 2024 |
EF Hutton | EF Hutton | Strong Buy Reiterates $4.5 | Strong Buy | Reiterates | $4.5 | +492.11% | Nov 21, 2023 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $2.1 → $2.5 | Buy | Maintains | $2.1 → $2.5 | +228.95% | Nov 16, 2023 |
Financial Forecast
Revenue This Year
1.05M
from 306.39K
Increased by 241.72%
Revenue Next Year
6.42M
from 1.05M
Increased by 512.80%
EPS This Year
-0.48
from -0.55
EPS Next Year
-0.40
from -0.48
Revenue Forecast
Revenue | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|---|
High | 1.4M | 10.6M | 29.6M | 89.5M | 186.0M | 287.7M |
Avg | 1.0M | 6.4M | 23.6M | 65.5M | 109.4M | 157.2M |
Low | 862,400 | 3.2M | 17.8M | 50.0M | 70.0M | 90.9M |
Revenue Growth
Revenue Growth | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|---|
High | 345.5% | 912.9% | 361.5% | 278.3% | 183.8% | 162.9% |
Avg | 241.7% | 512.8% | 268.6% | 177.0% | 67.0% | 43.6% |
Low | 181.5% | 208.9% | 177.5% | 111.3% | 6.8% | -16.9% |
EPS Forecast
EPS | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|
High | -0.44 | -0.38 | -0.30 | - |
Avg | -0.48 | -0.40 | -0.33 | - |
Low | -0.49 | -0.42 | -0.35 | - |
EPS Growth
EPS Growth | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|
High | - | - | - | - |
Avg | - | - | - | - |
Low | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.